• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Cardinal Health's Outcomes™ collaborates with Signify Health to offer in-home medication therapy management

    3/6/23 9:03:00 AM ET
    $CAH
    $SGFY
    Other Pharmaceuticals
    Health Care
    Retail: Computer Software & Peripheral Equipment
    Technology
    Get the next $CAH alert in real time by email

    DUBLIN, Ohio, March 6, 2023 /PRNewswire/ -- Cardinal Health (NYSE:CAH) today announced its collaboration with Signify Health (NYSE:SGFY) to offer in-home clinical and medication management services through its Outcomes™ business. This collaboration will help reduce costs and eliminate gaps in care for more than 2.3 million members nationwide to support their treatment journey from prescription to pharmacy to home.

    Cardinal Health, Inc. is a global, integrated healthcare services and products company, providing customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories and physician offices worldwide. (PRNewsfoto/Cardinal Health)

    Studies have shown that many members do not take their medications as prescribed. Bringing together Signify Health's1 mobile network of 11,000+ credentialed clinicians with Outcomes' industry leading OutcomesOne™ clinical care platform and omnichannel network of pharmacies and payers, this collaboration will help to address medication management challenges for health plan members by offering coordinated care from Signify Health clinicians who are also performing evaluations of those members in the home.

    Using the insights gathered during  in-home evaluations, Signify Health is able to use the OutcomesOne™ platform to identify and resolve the medication therapy management needs of members.

    "At Outcomes, we're working to revolutionize the healthcare journey by offering a more integrated experience that connects all sites of care," said Brent Stutz, senior vice president and general manager of Outcomes™. "As more patients recover and manage their chronic illnesses from home, this collaboration with Signify Health will help drive more powerful connections across transitions of care, enabling pharmacies and payers to reach patients who are often most in need of additional support."

    The collaboration will initially focus on addressing interventions recommended for Medicare Advantage members of joint clients and may expand into additional services, such as population health programs, and additional clinical interventions.

    "From our experience conducting medication reviews in thousands of homes each day, we understand the importance of making medication management more convenient, accessible and connected to daily life," said David Pierre, chief operating officer, Signify Health. "We look forward to joining forces with Outcomes to bring this vital service to improve medication safety and adherence and drive more value for the people we are privileged to serve."

    About Cardinal Health

    Cardinal Health is a distributor of pharmaceuticals, a global manufacturer and distributor of medical and laboratory products, and a provider of performance and data solutions for health care facilities. With 50 years in business, operations in more than 30 countries and approximately 46,500 employees globally, Cardinal Health is essential to care. Information about Cardinal Health is available at cardinalhealth.com.

    About Signify Health

    Signify Health is a leading healthcare platform that leverages advanced analytics, technology, and nationwide healthcare provider networks to create and power value-based payment programs. Our mission is to build trusted relationships to make people healthier. Our solutions support value-based payment programs by aligning financial incentives around outcomes, providing tools to health plans and healthcare organizations designed to assess and manage risk and identify actionable opportunities for improved patient outcomes, coordination and cost-savings. Through our platform, we coordinate what we believe is a holistic suite of clinical, social, and behavioral services to address an individual's healthcare needs and prevent adverse events that drive excess cost, all while shifting services towards the home.

    1 Reference to Signify Health's mobile network includes clinicians employed or contracted by Signify Health, LLC and/or one more physician-owned contracted provider groups.

    CONTACT: Shana Eiselstein, [email protected]

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/cardinal-healths-outcomes-collaborates-with-signify-health-to-offer-in-home-medication-therapy-management-301762858.html

    SOURCE Cardinal Health

    Get the next $CAH alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $CAH
    $SGFY

    CompanyDatePrice TargetRatingAnalyst
    Cardinal Health Inc.
    $CAH
    6/3/2025$179.00Equal Weight → Overweight
    Wells Fargo
    Cardinal Health Inc.
    $CAH
    2/5/2025$140.00 → $150.00Hold → Buy
    Jefferies
    Cardinal Health Inc.
    $CAH
    1/8/2025$130.00 → $144.00Hold → Buy
    TD Cowen
    Cardinal Health Inc.
    $CAH
    1/7/2025$140.00In-line → Outperform
    Evercore ISI
    Cardinal Health Inc.
    $CAH
    1/6/2025$132.00 → $145.00Neutral → Buy
    BofA Securities
    Cardinal Health Inc.
    $CAH
    12/13/2024$101.00 → $127.00Underweight → Equal Weight
    Wells Fargo
    Cardinal Health Inc.
    $CAH
    12/4/2024$139.00Outperform
    Mizuho
    Cardinal Health Inc.
    $CAH
    2/26/2024$125.00Outperform
    Leerink Partners
    More analyst ratings

    $CAH
    $SGFY
    SEC Filings

    See more
    • SEC Form 11-K filed by Cardinal Health Inc.

      11-K - CARDINAL HEALTH INC (0000721371) (Filer)

      6/20/25 8:32:15 AM ET
      $CAH
      Other Pharmaceuticals
      Health Care
    • SEC Form 11-K filed by Cardinal Health Inc.

      11-K - CARDINAL HEALTH INC (0000721371) (Filer)

      6/20/25 8:31:24 AM ET
      $CAH
      Other Pharmaceuticals
      Health Care
    • Cardinal Health Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - CARDINAL HEALTH INC (0000721371) (Filer)

      6/12/25 6:47:01 AM ET
      $CAH
      Other Pharmaceuticals
      Health Care

    $CAH
    $SGFY
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more

    $CAH
    $SGFY
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Chief Legal/Compliance Officer Mayer Jessica L covered exercise/tax liability with 5,176 shares, decreasing direct ownership by 9% to 55,110 units (SEC Form 4)

      4 - CARDINAL HEALTH INC (0000721371) (Issuer)

      6/30/25 4:18:28 PM ET
      $CAH
      Other Pharmaceuticals
      Health Care
    • CEO, GMPD Segment Mason Stephen M covered exercise/tax liability with 5,694 shares, decreasing direct ownership by 14% to 34,977 units (SEC Form 4)

      4 - CARDINAL HEALTH INC (0000721371) (Issuer)

      6/30/25 4:17:48 PM ET
      $CAH
      Other Pharmaceuticals
      Health Care
    • Chief Executive Officer Hollar Jason M. covered exercise/tax liability with 5,821 shares, decreasing direct ownership by 3% to 191,815 units (SEC Form 4)

      4 - CARDINAL HEALTH INC (0000721371) (Issuer)

      6/30/25 4:16:56 PM ET
      $CAH
      Other Pharmaceuticals
      Health Care
    • Cardinal Health to Announce Fourth-Quarter and Year-End Results for Fiscal Year 2025 on August 12

      DUBLIN, Ohio, July 15, 2025 /PRNewswire/ -- Cardinal Health (NYSE:CAH) plans to release fourth-quarter and year-end financial results for its fiscal year 2025 on August 12, prior to the opening of trading on the New York Stock Exchange. The company will webcast a discussion of these results beginning at 8:30 a.m. Eastern. To access the webcast and corresponding slide presentation, visit Cardinal Health's Investor Relations page. No access code is required. Presentation slides and a webcast replay will be available on the Investor Relations page for 12 months. About Cardinal He

      7/15/25 6:45:00 AM ET
      $CAH
      Other Pharmaceuticals
      Health Care
    • Cardinal Health announces One Voice Initiative to support independent pharmacy advocacy

      DUBLIN, Ohio, July 11, 2025 /PRNewswire/ -- Cardinal Health (NYSE:CAH) today announced the launch of the Cardinal Health™ One Voice Initiative for pharmacy advocacy, which provides direct financial assistance to state pharmacy associations for the purpose of supporting independent pharmacists' advocacy efforts.   This investment furthers Cardinal Health's longstanding advocacy around the future of independent pharmacies and ongoing partnerships with industry organizations to support pharmacists' efforts to build relationships with elected officials at all levels of government.

      7/11/25 8:30:00 AM ET
      $CAH
      Other Pharmaceuticals
      Health Care
    • After Major Oncology Conference, All Eyes Turn to Industry Innovation

      USA News Group News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, June 12, 2025 /PRNewswire/ -- After the close of the world's largest cancer conference (the 2025 American Society of Clinical Oncology annual meeting), doctors, scientists, and researchers are optimistic, especially in the fields of immunotherapy, Car T-cell therapy, liquid biopsies, breast cancer, AI, and even exercise. However, with reports coming out that the current US administration could drastically reduce funding of the National Cancer Institute (NCI) by nearly 40%, the market is looking towards the private sector to pick up the slack and continue to make advancements in cancer treatment. For inv

      6/12/25 9:00:00 AM ET
      $CAH
      $CTOR
      $CTXR
      $ONCY
      Other Pharmaceuticals
      Health Care
      Biotechnology: Pharmaceutical Preparations

    $CAH
    $SGFY
    Leadership Updates

    Live Leadership Updates

    See more
    • After Major Oncology Conference, All Eyes Turn to Industry Innovation

      USA News Group News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, June 12, 2025 /PRNewswire/ -- After the close of the world's largest cancer conference (the 2025 American Society of Clinical Oncology annual meeting), doctors, scientists, and researchers are optimistic, especially in the fields of immunotherapy, Car T-cell therapy, liquid biopsies, breast cancer, AI, and even exercise. However, with reports coming out that the current US administration could drastically reduce funding of the National Cancer Institute (NCI) by nearly 40%, the market is looking towards the private sector to pick up the slack and continue to make advancements in cancer treatment. For inv

      6/12/25 9:00:00 AM ET
      $CAH
      $CTOR
      $CTXR
      $ONCY
      Other Pharmaceuticals
      Health Care
      Biotechnology: Pharmaceutical Preparations
    • Carlisle Companies Announces Leadership Appointments

      Carlisle Companies Incorporated (NYSE:CSL) today announced the appointment of Christopher B. Gaskill as Vice President & General Counsel for the Company. In conjunction with this appointment, Scott C. Selbach will transition to a new role as Executive Vice President, Government Relations for the Company. Mr. Selbach will also remain Secretary of the Company. Both Mr. Gaskill and Mr. Selbach will report to Chris Koch, Carlisle's Chair, President & Chief Executive Officer. Prior to joining Carlisle, Mr. Gaskill served as Executive Vice President, Chief Legal Officer, and Secretary at Summit Materials, Inc. (NYSE:SUM), where he was responsible for the company's global legal functions and ensu

      5/16/25 4:05:00 PM ET
      $CAH
      $CSL
      $SUM
      $WU
      Other Pharmaceuticals
      Health Care
      Specialty Chemicals
      Industrials
    • Robert Musslewhite and Sudhakar Ramakrishna to join Cardinal Health Board of Directors

      DUBLIN, Ohio, March 10, 2025 /PRNewswire/ -- Cardinal Health (NYSE:CAH) announced today that its Board of Directors has elected Robert Musslewhite, former Chief Executive Officer of Definitive Healthcare Corp., and Sudhakar Ramakrishna, President and Chief Executive Officer of SolarWinds Corporation, as independent directors, effective March 7, 2025. With more than 20 years of leadership experience, including serving as CEO for two publicly traded companies, Mr. Musslewhite brings to the board unique expertise in advanced analytics, data, and technology across the healthcare e

      3/10/25 6:45:00 AM ET
      $CAH
      Other Pharmaceuticals
      Health Care

    $CAH
    $SGFY
    Financials

    Live finance-specific insights

    See more
    • Cardinal Health Board of Directors Approves Quarterly Dividend

      DUBLIN, Ohio, May 5, 2025 /PRNewswire/ -- Cardinal Health (NYSE:CAH) announced today that its Board of Directors approved an increase to its quarterly dividend, to $0.5107 per share, out of the Company's capital surplus. The dividend will be payable on July 15, 2025, to shareholders of record at the close of business on July 1, 2025. About Cardinal HealthCardinal Health is a distributor of pharmaceuticals and specialty products; a global manufacturer and distributor of medical and laboratory products; a supplier of home-health and direct-to-patient products and services; an op

      5/5/25 5:30:00 PM ET
      $CAH
      Other Pharmaceuticals
      Health Care
    • Cardinal Health Reports Third Quarter Fiscal Year 2025 Results and Raises Fiscal Year 2025 Outlook

      Revenue was flat at $54.9 billion; revenue increased 19% excluding the impact of the previously communicated customer contract expirationGAAP1 operating earnings were $730 million; GAAP diluted EPS was $2.10Non-GAAP operating earnings increased 21% to $807 million, driven by segment profit growth across all of the company's operating segments; non-GAAP diluted EPS increased 13% to $2.35Fiscal year 2025 non-GAAP EPS guidance2 raised and narrowed to $8.05 to $8.15, from $7.85 to $8.00GI Alliance announces expansion into urology specialty therapeutic areaDUBLIN, Ohio, May 1, 2025 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today reported third quarter fiscal year 2025 revenues of $54.9 billion,

      5/1/25 6:45:00 AM ET
      $CAH
      Other Pharmaceuticals
      Health Care
    • Cardinal Health Board of Directors Approves Quarterly Dividend

      DUBLIN, Ohio, Feb. 3, 2025 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved a quarterly dividend of $0.5056 per share out of the Company's capital surplus. The dividend will be payable on April 15, 2025, to shareholders of record at the close of business on April 1, 2025. About Cardinal HealthCardinal Health is a distributor of pharmaceuticals and specialty products; a global manufacturer and distributor of medical and laboratory products; a supplier of home-health and direct-to-patient products and services; an operator of nucle

      2/3/25 5:15:00 PM ET
      $CAH
      Other Pharmaceuticals
      Health Care

    $CAH
    $SGFY
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Cardinal Health upgraded by Wells Fargo with a new price target

      Wells Fargo upgraded Cardinal Health from Equal Weight to Overweight and set a new price target of $179.00

      6/3/25 7:24:57 AM ET
      $CAH
      Other Pharmaceuticals
      Health Care
    • Cardinal Health upgraded by Jefferies with a new price target

      Jefferies upgraded Cardinal Health from Hold to Buy and set a new price target of $150.00 from $140.00 previously

      2/5/25 7:09:45 AM ET
      $CAH
      Other Pharmaceuticals
      Health Care
    • Cardinal Health upgraded by TD Cowen with a new price target

      TD Cowen upgraded Cardinal Health from Hold to Buy and set a new price target of $144.00 from $130.00 previously

      1/8/25 7:36:58 AM ET
      $CAH
      Other Pharmaceuticals
      Health Care

    $CAH
    $SGFY
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Cardinal Health Inc. (Amendment)

      SC 13G/A - CARDINAL HEALTH INC (0000721371) (Subject)

      2/13/24 5:01:02 PM ET
      $CAH
      Other Pharmaceuticals
      Health Care
    • SEC Form SC 13G/A filed by Cardinal Health Inc. (Amendment)

      SC 13G/A - CARDINAL HEALTH INC (0000721371) (Subject)

      1/30/24 1:39:03 PM ET
      $CAH
      Other Pharmaceuticals
      Health Care
    • SEC Form SC 13G/A filed by Cardinal Health Inc. (Amendment)

      SC 13G/A - CARDINAL HEALTH INC (0000721371) (Subject)

      2/14/23 12:37:58 PM ET
      $CAH
      Other Pharmaceuticals
      Health Care